Gopish Pharma Limited
About Gopish Pharma Limited
Data last updated:
Gopish Pharma Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 April 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PLC067545. Its GSTIN is 07AABCG6958R1ZR (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹68 Lakh. It was formerly known as Gopish Pharma P Limited. It is led by directors including Santosh Goel and Ratish Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H 1455 Dsidc Industrial Complex Narela, Delhi, India – 110040.
As per the financials filed for FY 2025, the company reported a revenue of ₹25,000, a decline of 26% compared to the previous year. For the same year it recorded a net loss of ₹10.93 Lakh and EBITDA of ₹15,230 (EBITDA margin 60.9%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 60% over five years.
As per MCA filings, the company has open charges of ₹13.08 Cr on record. Court records list 65 cases involving the company, including 2 filed by the company and 61 filed against it; 11 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH 1455 Dsidc Industrial Complex Narela, Delhi, India – 110040
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Gopish Pharma Limited
The main business activity of Gopish Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gopish Pharma Limited FY 2025 filings available
Gopish Pharma Limited reported revenue of ₹25,000 (down 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Gopish Pharma Limited
Revenue has declined at a compounded annual rate (CAGR) of 60% over five years, including a 26% fall in the latest year. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gopish Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹15,230 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹10.93 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gopish Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 60.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gopish Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Gopish Pharma Limited
Gopish Pharma Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Proheal Formulations Private Limited | ₹26,828 (FY 2025) | •••• | •••• | 315.0% | •••• | Chandigarh, India |
| Raounak Drugs Private Limited | ₹25,880 (FY 2019) | •••• | •••• | •••• | Indore, Madhya Pradesh, India | |
| Panera Biotec Private Limited | ₹25,820 (FY 2024) | •••• | •••• | -100.0% | •••• | New Delhi, Delhi, India |
| Save Earth Labs Private Limited | ₹25,200 (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Emdon Pharmacy Private Limited | ₹25,065 (FY 2023) | •••• | •••• | •••• | Cuttack, Odisha, India | |
| Gopish Pharma Limited this company | ₹25,000 (FY 2025) | •••• | •••• | -26.0% | •••• | Delhi, India |
| Liventis Pharmceuticals Private Limited | ₹24,713 (FY 2024) | •••• | •••• | -80.0% | •••• | Palwal, Haryana, India |
| Synoglad Healthcare Private Limited | ₹24,628 (FY 2023) | •••• | •••• | -100.0% | •••• | Jaipur, Rajasthan, India |
| Aarranya Cosmeceuticals Private Limited | ₹24,618 (FY 2025) | •••• | •••• | -97.0% | •••• | Bangalore, Karnataka, India |
| Anu Pharma Private Limited | ₹24,336 (FY 2019) | •••• | •••• | -100.0% | •••• | Ramachandrapuram, Telangana, India |
| Vigoms Infrastructure & Development Private Limited | ₹23,700 (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Gopish Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Gopish Pharma Limited
Gopish Pharma Limited is audited by ASHOK AGGARWAL & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ASHOK AGGARWAL & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Gopish Pharma Limited
Gopish Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Goel | Director | 06 Sep 1995 | 31 Years 1 Months | Current |
| Ratish Goyal Also directs: Rallis Healthcare Private Limited | Director | 01 Jun 2008 | 18 Years 4 Months | Current |
| Ravi Parkash Goel Also directs: Rallis Healthcare Private Limited | Director | 06 Sep 1995 | 31 Years 1 Months | Current |
Ownership and Shareholding of Gopish Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gopish Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Aug 2011 | State Bank of Bikaner & Jaipur | ₹83 Lakh | Open |
| 25 Jun 2011 | State Bank of Bikaner & Jaipur | ₹7 Lakh | Open |
| 25 Nov 2006 | State Bank of Bikaner & Jaipur | ₹12.18 Cr | Open |
Total charge records: 3 View all charges
Legal Cases of Gopish Pharma Limited
Gopish Pharma Limited has 65 court cases on record: 2 filed by Gopish Pharma, 61 filed against it, 2 where it is another party. 11 cases are pending and 54 are disposed. Status as checked between 28 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 62 | 59 | 11 |
| High courts | 3 | 2 | 0 |
Cases on record (5 of 65)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Amritsar, Punjab | Cheque dishonour complaint | Filed against the company by Goliath Exim Private Limited | Disposed |
| District court, Amritsar, Punjab | Criminal miscellaneous application | Filed against the company by Goliath Exim Private Limited | Disposed |
| District court, Amritsar, Punjab | Bail application | Filed against the company by Goliath Exim Private Limited | Disposed |
| District court, North West, Delhi | Criminal case | Filed against the company by Modern Laminators Private Limited | Disposed |
| District court, Jhajjar, Haryana | Appeal | Filed by the company against Pendo Plast Private Limited | Disposed |
Full case history
All 65 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Gopish Pharma Limited
Employment history and EPFO contributions of people linked to Gopish Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gopish Pharma Limited
Gopish Pharma Limited has 5 board changes on record since 1995: 3 appointments and 2 cessations. The latest: Parveen Kumar ceased to be Director on 30 Sep 2009.
Credit Ratings, Litigation & Regulatory Alerts for Gopish Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gopish Pharma Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gopish Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gopish Pharma Limited
Gopish Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCG6958R1ZR | Delhi | Active | 01 Jul 2017 |
| 02AABCG6958R1Z1 | Himachal Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gopish Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gopish Pharma Limited
Gopish Pharma is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 April 1995 (31+ years old) and is registered under CIN U74899DL1995PLC067545.
Gopish Pharma reported revenue of ₹25,000 for FY 2025 (down 26% YoY).
Gopish Pharma has 3 current directors:
- Santosh Goel - Director
- Ratish Goyal - Director
- Ravi Parkash Goel - Director
Gopish Pharma reported a net loss of ₹10.93 Lakh and EBITDA of ₹15,230 (EBITDA margin 60.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gopish Pharma is 10% over three years and -60% over five years. In the latest year (FY 2025) revenue fell 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Gopish Pharma is 07AABCG6958R1ZR, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AABCG6958R1Z1 (Himachal Pradesh).
The CIN (Corporate Identification Number) of Gopish Pharma is U74899DL1995PLC067545. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gopish Pharma has 65 court cases on record: 2 filed by the company and 61 filed against it. 11 are pending. Most are in the district courts.
Gopish Pharma was incorporated on 20 April 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Gopish Pharma by revenue are Proheal Formulations Private Limited, Raounak Drugs Private Limited, Panera Biotec Private Limited, Save Earth Labs Private Limited, Emdon Pharmacy Private Limited and 5 more, all in the Pharma industry (Formulations).
Parveen Kumar ceased to be Director on 30 Sep 2009. Ratish Goyal was appointed as Director on 01 Jun 2008. Ratish Goyal ceased to be Director on 08 May 2008. Gopish Pharma has 5 board changes on record in total.